New drug combo plus radiation targets tough uterine cancer
Disease control
Recruiting now
This early-stage trial is testing whether combining two cancer drugs (lenvatinib and pembrolizumab) with a shorter course of pelvic radiation is safe for people with recurrent or unresectable endometrial cancer. The study aims to find the best dose of lenvatinib when used in this…
Phase 1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC